160 related articles for article (PubMed ID: 30209569)
21. Preventive effect of Diallyl Trisulfide on cutaneous toxicities induced by EGFR inhibitor.
Liu Y; Jiang X; Gu Y; Chen Y
Int Immunopharmacol; 2019 Apr; 69():79-87. PubMed ID: 30682720
[TBL] [Abstract][Full Text] [Related]
22. Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth.
Lai KC; Hsu SC; Yang JS; Yu CC; Lein JC; Chung JG
J Cell Mol Med; 2015 Feb; 19(2):474-84. PubMed ID: 25403643
[TBL] [Abstract][Full Text] [Related]
23. Diallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activation.
Yu L; Li S; Tang X; Li Z; Zhang J; Xue X; Han J; Liu Y; Zhang Y; Zhang Y; Xu Y; Yang Y; Wang H
Apoptosis; 2017 Jul; 22(7):942-954. PubMed ID: 28455824
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
Marampon F; Leoni F; Mancini A; Pietrantoni I; Codenotti S; Ferella L; Megiorni F; Porro G; Galbiati E; Pozzi P; Mascagni P; Budillon A; Maggio R; Tombolini V; Fanzani A; Gravina GL; Festuccia C
J Cancer Res Clin Oncol; 2019 Feb; 145(2):393-409. PubMed ID: 30474756
[TBL] [Abstract][Full Text] [Related]
25. Diallyl trisulfide ameliorates arsenic-induced hepatotoxicity by abrogation of oxidative stress, inflammation, and apoptosis in rats.
Sumedha NC; Miltonprabu S
Hum Exp Toxicol; 2015 May; 34(5):506-25. PubMed ID: 25062976
[TBL] [Abstract][Full Text] [Related]
26. [Diallyl trisulfide induces apoptosis of human gastric cancer cell line MGC803 through caspase-3 pathway].
Xiao XL; Peng J; Su Q; Xiang SL; Tang GH; Huang YS; Zhou XT
Ai Zheng; 2006 Oct; 25(10):1247-51. PubMed ID: 17059769
[TBL] [Abstract][Full Text] [Related]
27. Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.
Garrett LA; Growdon WB; Rueda BR; Foster R
J Ovarian Res; 2016 Sep; 9(1):58. PubMed ID: 27633667
[TBL] [Abstract][Full Text] [Related]
28. Diallyl trisulfide, a H
Xu S; Pan J; Cheng X; Zheng J; Wang X; Guan H; Yu H; Bao J; Zhang L
Phytother Res; 2020 May; 34(5):1154-1165. PubMed ID: 31984539
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.
Gravina GL; Mancini A; Mattei C; Vitale F; Marampon F; Colapietro A; Rossi G; Ventura L; Vetuschi A; Di Cesare E; Fox JA; Festuccia C
Oncotarget; 2017 May; 8(18):29865-29886. PubMed ID: 28415741
[TBL] [Abstract][Full Text] [Related]
30. Diallyl trisulfide protects against ethanol-induced oxidative stress and apoptosis via a hydrogen sulfide-mediated mechanism.
Chen LY; Chen Q; Zhu XJ; Kong DS; Wu L; Shao JJ; Zheng SZ
Int Immunopharmacol; 2016 Jul; 36():23-30. PubMed ID: 27107369
[TBL] [Abstract][Full Text] [Related]
31. Reversion of P-glycoprotein-mediated multidrug resistance by diallyl trisulfide in a human osteosarcoma cell line.
Wang Z; Xia Q; Cui J; Diao Y; Li J
Oncol Rep; 2014 Jun; 31(6):2720-6. PubMed ID: 24788927
[TBL] [Abstract][Full Text] [Related]
32. Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells.
Xiao D; Zeng Y; Hahm ER; Kim YA; Ramalingam S; Singh SV
Environ Mol Mutagen; 2009 Apr; 50(3):201-12. PubMed ID: 18800351
[TBL] [Abstract][Full Text] [Related]
33. A proteomic study on a human osteosarcoma cell line Saos-2 treated with diallyl trisulfide.
Zhang YK; Zhang XH; Li JM; Sun DS; Yang Q; Diao DM
Anticancer Drugs; 2009 Sep; 20(8):702-12. PubMed ID: 19550292
[TBL] [Abstract][Full Text] [Related]
34. Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice.
Singh SV; Powolny AA; Stan SD; Xiao D; Arlotti JA; Warin R; Hahm ER; Marynowski SW; Bommareddy A; Potter DM; Dhir R
Cancer Res; 2008 Nov; 68(22):9503-11. PubMed ID: 19010926
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
[TBL] [Abstract][Full Text] [Related]
36. Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells.
Grinshtein N; Rioseco CC; Marcellus R; Uehling D; Aman A; Lun X; Muto O; Podmore L; Lever J; Shen Y; Blough MD; Cairncross GJ; Robbins SM; Jones SJ; Marra MA; Al-Awar R; Senger DL; Kaplan DR
Oncotarget; 2016 Sep; 7(37):59360-59376. PubMed ID: 27449082
[TBL] [Abstract][Full Text] [Related]
37. Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma.
Zhang Y; Ishida CT; Ishida W; Lo SL; Zhao J; Shu C; Bianchetti E; Kleiner G; Sanchez-Quintero MJ; Quinzii CM; Westhoff MA; Karpel-Massler G; Canoll P; Siegelin MD
Clin Cancer Res; 2018 Aug; 24(16):3941-3954. PubMed ID: 29764852
[No Abstract] [Full Text] [Related]
38. Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways.
Shin DY; Kim GY; Hwang HJ; Kim WJ; Choi YH
Environ Toxicol Pharmacol; 2014 Jan; 37(1):74-83. PubMed ID: 24309133
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems.
Nguyen TTT; Zhang Y; Shang E; Shu C; Quinzii CM; Westhoff MA; Karpel-Massler G; Siegelin MD
Cells; 2020 Jul; 9(7):. PubMed ID: 32664214
[TBL] [Abstract][Full Text] [Related]
40. Caspase-8 and p38MAPK in DATS-induced apoptosis of human CNE2 cells.
Ji C; Ren F; Xu M
Braz J Med Biol Res; 2010 Sep; 43(9):821-7. PubMed ID: 20802973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
